BioNexus Gene Lab Plunges 35.37% Post Reverse Split

On July 2, 2025, BioNexus Gene Lab experienced a significant drop of 35.37% in pre-market trading, marking a notable shift in its stock performance.

BioNexus Gene Lab recently conducted a 1 for 10 reverse stock split, which means shareholders now hold 1 share for every 10 shares they previously owned. This corporate action is aimed at increasing the stock price and potentially attracting more investors by making the shares more valuable on a per-share basis.

Prior to the recent drop, BioNexus Gene Lab had seen substantial gains, with its stock price surging by over 200% in previous trading sessions. This volatility reflects the company's dynamic market position and the potential for significant price movements based on investor sentiment and market conditions.